Pathology News

News

Currently Browsing:2017

  • Pathology and a path to great clinical care

    Friday, April 14, 2017  Mass General

    In late 2014, after a routine annual physical, Cape Cod resident Barbara Porter was diagnosed with pancytopenia, a reduction of red and white blood cells and platelets.

Currently Browsing:2016

  • Once again, named among America's best hospitals

    Tuesday, August 2, 2016  Mass General

    Massachusetts General Hospital is once again named among the top hospitals in America by U.S. News & World Report and is the only hospital to be highly rated across all 16 specialties.

  • A week to honor medical laboratory professionals

    Friday, April 15, 2016  Mass General

    Medical laboratory professionals week – an annual celebration of laboratory professionals and pathologists who play a vital role in every aspect of health care – runs from April 24-30.

Currently Browsing:2014

  • #1 in New England, #2 in the nation

    Tuesday, July 15, 2014  Mass General

    U.S. News & World Report ranks Massachusetts General Hospital among the top hospitals in America based on our quality of care, patient safety and reputation in 16 specialties.

Currently Browsing:2013

  • #1 in New England, #2 in the nation

    Tuesday, July 16, 2013  Mass General

    U.S. News & World Report ranks Massachusetts General Hospital among the top hospitals in America based on our quality of care, patient safety and reputation in 16 specialties.

  • Getz, Raje honored with endowed chairs in oncology

    Friday, May 24, 2013  Mass General

    The MGH honored two staff members this month as inaugural recipients of endowed chairs in oncology, both made possible thanks to the generosity of an anonymous donor.

Currently Browsing:2012

  • In Memoriam: Robert E. Scully, MD

    Friday, November 9, 2012  Mass General

    Robert E. Scully, MD, a giant in the field of pathology and a beloved member of the MGH family for more than 55 years, died Oct. 30 at the age of 91

  • Major NIH grants support innovative research projects

    Friday, September 28, 2012  Mass General

    Two MGH-led research teams and one MGH investigator have received major grants from the National Institutes of Health.

  • 2012 Research Scholars announced

    Friday, May 25, 2012  Mass General

    The second group of MGH Research Scholars – recipients of unrestricted five-year grants to support innovative investigations – was announced at the hospital’s Research Advisory Council (RAC) annual meeting on May 11.

Currently Browsing:2011

Currently Browsing:2010

Currently Browsing:2009

  • Bernstein and Hochedlinger among 50 HHMI Early Career Scientists

    Friday, May 15, 2009  Research

    MGH Hotline 5.15.09 Two MGH scientists — Bradley Bernstein, MD, PhD, of the Department of Pathology, and Konrad Hochedlinger, PhD, of the Center for Regenerative Medicine – are among the first group of Howard Hughes Medical Institute (HHMI) Early Career Scientists.

Media Coverage

  • Highly Cited Researchers - Clarivate Analytics, 10/11/2018

    Dr. Bernstein, Dr. Getz and Dr. Joung have made the Thomson Reuters 2016 Highly Cited Researchers list!

  • Creative Minds: A New Way to Look at Cancer - NIH Director's Blog, 10/10/2018

    Dr. Bernstein's work with DNA packaging has been mentioned in National Institutes of Health Director's Blog; Creative Minds: A New Way to Look at Cancer

  • In vivo CRISPR editing with no detectable genome-wide off-target mutations - Pub Med, 9/18/2018

    CRISPR-Cas genome-editing nucleases hold substantial promise for developing human therapeutic applications1-6 but identifying unwanted off-target mutations is important for clinical translation7. A well-validated method that can reliably identify off-targets in vivo has not been described to date, which means it is currently unclear whether and how frequently these mutations occur. Here we describe 'verification of in vivo off-targets' (VIVO), a highly sensitive strategy that can robustly identify the genome-wide off-target effects of CRISPR-Cas nucleases in vivo. We use VIVO and a guide RNA deliberately designed to be promiscuous to show that CRISPR-Cas nucleases can induce substantial off-target mutations in mouse livers in vivo.

  • Tumours of the Central Nervous System (CNS) - International Collaboration on Cancer Reporting, 8/1/2018

    The International Collaboration on Cancer Reporting has published its first datasets on central nervous system tumors. These provide guidelines and detailed background information relating to diagnostic pathology reporting and are intended to influence practice around the world. Development of the central nervous system tumor datasets was directed by Dr. David Louis, chair of MGH Pathology.

  • A New Approach For Cancer DNA Blood Biopsies - RELIAWIRE, 11/6/2017

    An accurate, scalable approach for monitoring cancer DNA from blood samples has been developed by researchers at the Broad Institute of MIT and Harvard, Koch Institute at MIT, Dana-Farber Cancer Institute, and Massachusetts General Hospital.

Video

  • Celebrating 200 Years: 1811 - 2011

    Celebrating 200 Years: 1811 - 2011

    Since 1811, people have counted on Mass General for answers, innovations and medical leadership. As our third century dawns, we remain ready to serve.

Press Releases

Currently Browsing:2018

Currently Browsing:2017

Currently Browsing:2016

Currently Browsing:2015

Currently Browsing:2014

Currently Browsing:2013

Currently Browsing:2012

Currently Browsing:2011

  • Mass. General study finds amplification of multiple cell-growth genes in some brain tumors - 12/1/2011, Research

    A small percentage of the deadly brain tumors called glioblastomas, which usually resist treatment with drugs targeting mutations in cell-growth genes, appears to contain extra copies of two or three of these genes at the same time. The surprising discovery has major implications for the understanding of tumor biology and for targeted cancer therapies.

  • Combined arterial imaging technology reveals both structural and metabolic details - 11/6/2011, Research

    A new device that combines two microimaging technologies can reveal both the detailed anatomy of arterial linings and biological activities that, in coronary arteries, could indicate the risk of heart attacks or the formation of clots in arterial stents.

  • High-resolution imaging technology reveals cellular details of coronary arteries - 7/10/2011, Research

    Researchers at the Wellman Center for Photomedicine at MGH have developed a one-micrometer-resolution version of the intravascular imaging technology optical coherence tomography that can reveal cellular and subcellular features of coronary artery disease.

  • Epigenomic findings illuminate veiled variants - 3/23/2011, Research

    Genes make up only a tiny percentage of the human genome, but the rest may hold vital clues about the genetic origins of disease. Using a new mapping strategy, a research team has begun to assign meaning to the regions beyond our genes and has revealed how minute changes in these regions might be connected to common diseases.

Currently Browsing:2010

Currently Browsing:2009

Other Pathology News

Back to Top